JP2016508999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508999A5 JP2016508999A5 JP2015556184A JP2015556184A JP2016508999A5 JP 2016508999 A5 JP2016508999 A5 JP 2016508999A5 JP 2015556184 A JP2015556184 A JP 2015556184A JP 2015556184 A JP2015556184 A JP 2015556184A JP 2016508999 A5 JP2016508999 A5 JP 2016508999A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- composition
- hepatitis
- coronavirus
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759131P | 2013-01-31 | 2013-01-31 | |
| US61/759,131 | 2013-01-31 | ||
| PCT/US2014/014284 WO2014121132A1 (en) | 2013-01-31 | 2014-01-31 | Immunogenic compositions comprising silicified virus and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508999A JP2016508999A (ja) | 2016-03-24 |
| JP2016508999A5 true JP2016508999A5 (enExample) | 2017-02-23 |
| JP6300827B2 JP6300827B2 (ja) | 2018-03-28 |
Family
ID=51263001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556184A Expired - Fee Related JP6300827B2 (ja) | 2013-01-31 | 2014-01-31 | ケイ化ウイルスを含む免疫原性組成物および使用の方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9993543B2 (enExample) |
| EP (1) | EP2950817B1 (enExample) |
| JP (1) | JP6300827B2 (enExample) |
| KR (1) | KR102141887B1 (enExample) |
| CN (1) | CN105025922B (enExample) |
| AU (1) | AU2014212104B2 (enExample) |
| BR (1) | BR112015017966A2 (enExample) |
| CA (1) | CA2899461C (enExample) |
| IL (1) | IL240227A0 (enExample) |
| RU (1) | RU2676083C2 (enExample) |
| WO (1) | WO2014121132A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2961768A4 (en) | 2013-03-01 | 2016-10-26 | New York Blood Ct Inc | IMMUNOGENIC COMPOSITION AGAINST MERS CORONA VIRUS INFECTIONS |
| WO2014172685A1 (en) | 2013-04-18 | 2014-10-23 | The Regents Of The University Of California | Nanoscale coatings for encapsulation of biological entities |
| US11103575B2 (en) | 2014-02-28 | 2021-08-31 | The New York Blood Center, Inc. | Immunogenic composition for MERS coronavirus infection |
| US11357830B2 (en) | 2016-03-03 | 2022-06-14 | The Regents Of The University Of California | Nano-scale delivery device and uses thereof |
| WO2019055620A1 (en) | 2017-09-13 | 2019-03-21 | Stc. Unm | SILICIFIED CELL REPLICAS, METHODS OF MANUFACTURE, AND METHODS OF USE |
| RU2709659C1 (ru) * | 2018-09-06 | 2019-12-19 | федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Иммунобиологическое средство и способ его использования для индукции специфического иммунитета к вирусу ближневосточного респираторного синдрома (варианты) |
| CN111363017B (zh) * | 2018-12-25 | 2022-03-15 | 中国科学院微生物研究所 | A型流感病毒核蛋白s69位突变序列及其突变体与应用 |
| WO2020185449A1 (en) * | 2019-03-08 | 2020-09-17 | Stc.Unm | Silicified immunogenic cells, methods of making, and methods of using |
| US20230149456A1 (en) * | 2020-03-30 | 2023-05-18 | Unm Rainforest Innovations | Nanoparticle-loaded silicified cells, methods of making, and methods of use |
| EP4213875A4 (en) * | 2020-09-15 | 2024-09-18 | Bharat Biotech International Limited | TOLL-LIKE RECEPTOR (TLR) AGONIST VACCINE FORMULATION |
| GB202201188D0 (en) * | 2022-01-31 | 2022-03-16 | Univ Bath | Particle comprising a virus |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4344805B2 (ja) * | 2000-07-07 | 2009-10-14 | 独立行政法人科学技術振興機構 | 遺伝子組換えワクシニアウイルスワクチン |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| JP5584407B2 (ja) | 2008-03-07 | 2014-09-03 | 公益財団法人東京都医学総合研究所 | Ｃ型肝炎ウイルス遺伝子を有する組換えワクシニアウイルス |
| WO2010003009A2 (en) * | 2008-07-01 | 2010-01-07 | Emory University | Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| DE102008033175A1 (de) * | 2008-07-15 | 2010-01-21 | Merck Patent Gmbh | Siliciumdioxid-Nanopartikel und deren Verwendung zur Vakzinierung |
| RU2440098C2 (ru) * | 2009-01-15 | 2012-01-20 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН МНИИЭМ им. Г.Н. Габричевского Роспотребнадзора) | Препарат, содержащий биологически активные действующие вещества |
| US8383237B2 (en) | 2009-06-01 | 2013-02-26 | University Of Maryland, College Park | Preparation of silica stabilized biological templates for the production of metal and layered nanoparticles |
| GB201002419D0 (en) | 2010-02-12 | 2010-03-31 | Isis Innovation | Stable live vaccine formulations |
| JP6013185B2 (ja) | 2010-10-15 | 2016-10-25 | 公益財団法人東京都医学総合研究所 | 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有する組換えワクシニアウイルス |
| WO2012162428A1 (en) | 2011-05-23 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prime-boost vaccination for viral infection |
-
2014
- 2014-01-31 US US14/763,947 patent/US9993543B2/en active Active
- 2014-01-31 EP EP14745410.2A patent/EP2950817B1/en active Active
- 2014-01-31 CA CA2899461A patent/CA2899461C/en active Active
- 2014-01-31 AU AU2014212104A patent/AU2014212104B2/en not_active Ceased
- 2014-01-31 RU RU2015136683A patent/RU2676083C2/ru active
- 2014-01-31 KR KR1020157023031A patent/KR102141887B1/ko not_active Expired - Fee Related
- 2014-01-31 BR BR112015017966A patent/BR112015017966A2/pt active Search and Examination
- 2014-01-31 JP JP2015556184A patent/JP6300827B2/ja not_active Expired - Fee Related
- 2014-01-31 WO PCT/US2014/014284 patent/WO2014121132A1/en not_active Ceased
- 2014-01-31 CN CN201480010433.3A patent/CN105025922B/zh not_active Expired - Fee Related
-
2015
- 2015-07-29 IL IL240227A patent/IL240227A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016508999A5 (enExample) | ||
| RU2015136683A (ru) | Иммуногенные композиции, содержащие силикатированный вирус, и способы применения | |
| ES2562456T3 (es) | Uso de un adyuvante que induce una respuesta inmune Th1 para mejorar las respuestas inmunes | |
| JP2009539965A5 (enExample) | ||
| RU2017137357A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| JP2014532620A5 (enExample) | ||
| JP2008534467A5 (enExample) | ||
| JP2014520117A5 (enExample) | ||
| Choudhury et al. | Chemotherapy vs. Immunotherapy in combating nCOVID19: An update | |
| MY166534A (en) | Recombinant subunit dengue virus vaccine | |
| TW200722101A (en) | Novel composition | |
| HRP20210608T1 (hr) | Postupci i pripravci za induciranje zaštitnog imuniteta protiv infekcije virusom humane imunodeficijencije | |
| JP2019505560A5 (enExample) | ||
| JP2011504486A5 (enExample) | ||
| JP2013542224A5 (enExample) | ||
| JP2017526689A5 (enExample) | ||
| NZ618158A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| MX2010006984A (es) | Vacunas contra la malaria. | |
| ES2351489T3 (es) | Vacunas mejoradas. | |
| CO2022011392A2 (es) | Vacuna contra hpv | |
| JP2019520090A (ja) | 弱毒変異型ジカウイルスを含むワクチン組成物 | |
| US20170021009A1 (en) | Heat Inactivated Poxvirus Improves Vaccination Results | |
| WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
| AR065765A1 (es) | Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias | |
| RU2008114841A (ru) | Фармацевтическая композиция, способная индуцировать защитный иммунный ответ против вируса денге, содержащая капсидный белок этого вируса |